Neurocrine Biosciences, Inc. (BIT:1NBIX)
Italy · Delayed Price · Currency is EUR 107.70
0.00 (0.00%)
At close: Aug 8, 2025, 5:30 PM CET
Neurocrine Biosciences Market Cap
Neurocrine Biosciences has a market cap or net worth of €11.26 billion as of August 15, 2025. Its market cap has decreased by -14.41% in one year.
Market Cap
11.26B
Enterprise Value
10.84B
Revenue
2.14B
Ranking
n/a
PE Ratio
37.96
Stock Price
€107.70
Market Cap Chart
Since May 23, 1996, Neurocrine Biosciences's market cap has increased from 167.33M to 11.26B, an increase of 6,627.17%. That is a compound annual growth rate of 15.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 11.18B | -16.26% |
| Dec 31, 2024 | 13.35B | 13.98% |
| Dec 29, 2023 | 11.71B | 9.01% |
| Dec 30, 2022 | 10.74B | 51.23% |
| Dec 31, 2021 | 7.10B | -2.95% |
| Dec 31, 2020 | 7.32B | -17.01% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UniCredit | 107.40B |
| Intesa Sanpaolo | 97.13B |
| Enel SpA | 81.43B |
| Ferrari | 70.84B |
| Assicurazioni Generali | 51.89B |
| Eni S.p.A. | 45.41B |
| Leonardo S.p.a. | 27.55B |
| Poste Italiane | 26.13B |